Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.107.157172
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)